Filing Flows › Globus Medical (GMED) › Q1 2025
Globus Medical (GMED) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Globus Medical (GMED) reported revenue of $598M for the first quarter 2025 (Q1 2025), -1% from a year earlier and -9% from the quarter before. Operating margin was 16.2%, net earnings $75.5M (12.6% of revenue).
Globus Medical, Q1 2025: revenue $598M (-1% year over year), operating margin 16.2%, net earnings $75.5M, operating cash flow $177M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $598M | -9% | -1% |
| Operating profit | $97.0M | +61% | 12× |
| Net earnings | $75.5M | +185% | — |
| Operating cash flow | $177M | -16% | +238% |
| Free cash flow | $141M | — | +493% |
What changed
Revenue was $598.1M in Q1 2025, down 1% year over year and down 9% from the previous quarter. Musculoskeletal Solutions was the largest line at 96% of revenue. Enabling Technologies lost $9.8M year over year (down 31%), 114% of the total change.
Operating profit was $97.0M, a 16.2% margin (up 14.9 points year over year). Net earnings were $75.5M. The effective tax rate was 27.2%.
Operating cash flow was $177.3M (up 238% year over year), 235% of net earnings. Non-cash charges added back $65.7M of depreciation and amortization and $13.2M of share-based compensation. Working capital and other items added $23.0M. After purchases of property and equipment ($36.1M), free cash flow as the company reports it was $141.2M.
Questions
What was Globus Medical's revenue in the first quarter 2025?
Globus Medical (GMED) reported revenue of $598M for the first quarter 2025 (Q1 2025), -1% from a year earlier and -9% from the quarter before.
Was Globus Medical profitable in the first quarter 2025?
Operating profit was $97.0M (16.2% of revenue) and net earnings $75.5M.
Source: Globus Medical 10-Q on SEC EDGAR.